Literature DB >> 19001205

Patient awareness of chronic kidney disease: trends and predictors.

Laura C Plantinga1, L Ebony Boulware, Josef Coresh, Lesley A Stevens, Edgar R Miller, Rajiv Saran, Kassandra L Messer, Andrew S Levey, Neil R Powe.   

Abstract

BACKGROUND: The impact of recent guidelines for early detection and prevention of chronic kidney disease (CKD) on patient awareness of disease and factors that might be associated with awareness have not been well described.
METHODS: Awareness rates were assessed in 2992 adults (age, > or =20 years) with CKD stages 1 to 4 from a nationally representative, cross-sectional survey (National Health and Nutrition Examination Survey 1999-2004). Awareness of CKD was defined by an answer of yes to "Have you ever been told you have weak or failing kidneys?" Potential predictors of awareness included demographics, access to care, and clinical and lifestyle factors, which were assessed by standardized interviewer-administered questionnaires and physical examinations. We examined independent associations of patient characteristics with awareness in those with CKD stage 3 (n = 1314) over 6 years using multivariable logistic regression.
RESULTS: Awareness improved over time in those with CKD stage 3 only (4.7% [95% confidence interval {CI}, 2.6%-8.5%], 8.9% [95% CI, 7.1%-11.2%], and 9.2% [95% CI, 6.1%-13.8%] for 1999-2000, 2001-2002, and 2003-2004, respectively; P = .04, adjusted for age, sex, and race). Having proteinuria (odds ratio, 3.04 [95% CI, 1.62-5.70]), diabetes (OR, 2.19 [95% CI, 1.03-4.64]), and hypertension (OR, 2.92 [95% CI, 1.57-5.42]) and being male (OR, 2.06 [95% CI, 1.15-3.69]) were all statistically significantly associated with greater awareness among persons with CKD stage 3 after adjustment. Chronic kidney disease awareness increased almost 2-fold for those with CKD stage 3 over recent years but remains low. Persons with risk factors for CKD (proteinuria, diabetes, hypertension, and male sex) were more likely to be aware of their stage 3 disease.
CONCLUSION: Renewed and innovative efforts should be made to increase CKD awareness among patients and health care providers.

Entities:  

Mesh:

Year:  2008        PMID: 19001205      PMCID: PMC2652122          DOI: 10.1001/archinte.168.20.2268

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  20 in total

1.  Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race.

Authors:  Holly J Mattix; Chi-Yuan Hsu; Shimon Shaykevich; Gary Curhan
Journal:  J Am Soc Nephrol       Date:  2002-04       Impact factor: 10.121

2.  The timing of specialist evaluation in chronic kidney disease and mortality.

Authors:  Kraig S Kinchen; John Sadler; Nancy Fink; Ronald Brookmeyer; Michael J Klag; Andrew S Levey; Neil R Powe
Journal:  Ann Intern Med       Date:  2002-09-17       Impact factor: 25.391

3.  Prevalence of chronic kidney disease in the United States.

Authors:  Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey
Journal:  JAMA       Date:  2007-11-07       Impact factor: 56.272

4.  Age affects outcomes in chronic kidney disease.

Authors:  Ann M O'Hare; Andy I Choi; Daniel Bertenthal; Peter Bacchetti; Amit X Garg; James S Kaufman; Louise C Walter; Kala M Mehta; Michael A Steinman; Michael Allon; William M McClellan; C Seth Landefeld
Journal:  J Am Soc Nephrol       Date:  2007-09-12       Impact factor: 10.121

5.  Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004.

Authors:  Elizabeth Selvin; Jane Manzi; Lesley A Stevens; Frederick Van Lente; David A Lacher; Andrew S Levey; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2007-12       Impact factor: 8.860

6.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

7.  Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans.

Authors:  Lawrence J Appel; Jackson T Wright; Tom Greene; John W Kusek; Julia B Lewis; Xuelei Wang; Michael S Lipkowitz; Keith C Norris; George L Bakris; Mahboob Rahman; Gabriel Contreras; Stephen G Rostand; Joel D Kopple; Francis B Gabbai; Gerald I Schulman; Jennifer J Gassman; Jeanne Charleston; Lawrence Y Agodoa
Journal:  Arch Intern Med       Date:  2008-04-28

8.  Chronic kidney disease and cardiovascular disease in the Medicare population.

Authors:  Allan J Collins; Shuling Li; David T Gilbertson; Jiannong Liu; Shu-Cheng Chen; Charles A Herzog
Journal:  Kidney Int Suppl       Date:  2003-11       Impact factor: 10.545

9.  Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004.

Authors:  Yechiam Ostchega; Charles F Dillon; Jeffery P Hughes; Margaret Carroll; Sarah Yoon
Journal:  J Am Geriatr Soc       Date:  2007-07       Impact factor: 5.562

10.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.

Authors:  Josef Coresh; Brad C Astor; Tom Greene; Garabed Eknoyan; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2003-01       Impact factor: 8.860

View more
  128 in total

1.  A Case for Early Screening for Diabetic Kidney Disease.

Authors:  Adam Whaley-Connell; Kunal Chaudhary; Madhukar Misra; Ramesh Khanna
Journal:  Cardiorenal Med       Date:  2011-10-05       Impact factor: 2.041

2.  Awareness of kidney disease and relationship to end-stage renal disease and mortality.

Authors:  Adam Whaley-Connell; Michael G Shlipak; Lesley A Inker; Manjula Kurella Tamura; Andrew S Bomback; Georges Saab; Susanna M Szpunar; Samy I McFarlane; Suying Li; Shu-Cheng Chen; Keith Norris; George L Bakris; Peter A McCullough
Journal:  Am J Med       Date:  2012-05-23       Impact factor: 4.965

Review 3.  Validation of CKD and related conditions in existing data sets: A systematic review.

Authors:  Morgan E Grams; Laura C Plantinga; Elizabeth Hedgeman; Rajiv Saran; Gary L Myers; Desmond E Williams; Neil R Powe
Journal:  Am J Kidney Dis       Date:  2010-08-06       Impact factor: 8.860

4.  Epidemiology of chronic kidney disease among normotensives: but what is chronic kidney disease?

Authors:  Rajiv Agarwal
Journal:  Hypertension       Date:  2010-03-22       Impact factor: 10.190

5.  State medicaid coverage, ESRD incidence, and access to care.

Authors:  Manjula Kurella-Tamura; Benjamin A Goldstein; Yoshio N Hall; Aya A Mitani; Wolfgang C Winkelmayer
Journal:  J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 10.121

6.  Is awareness of chronic kidney disease associated with evidence-based guideline-concordant outcomes?

Authors:  Delphine S Tuot; Laura C Plantinga; Chi-yuan Hsu; Neil R Powe
Journal:  Am J Nephrol       Date:  2012-01-27       Impact factor: 3.754

7.  Hypertension: the message of World Kidney Day 2009.

Authors:  George L Bakris; Eberhard Ritz
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

8.  Chronic kidney disease: Automated eGFR reporting: good for the patient?

Authors:  Andrew D Rule; LaTonya J Hickson
Journal:  Nat Rev Nephrol       Date:  2009-12       Impact factor: 28.314

9.  A pilot trial of a computerized renal template note to improve resident knowledge and documentation of kidney disease.

Authors:  S Shirazian; R Wang; D Moledina; V Liberman; J Zeidan; D Strand; J Mattana
Journal:  Appl Clin Inform       Date:  2013-11-13       Impact factor: 2.342

10.  Lifetime Risk of Stage 3-5 CKD in a Community-Based Sample in Iceland.

Authors:  Lesley A Inker; Hocine Tighiouart; Thor Aspelund; Vilmundur Gudnason; Tamara Harris; Olafur S Indridason; Runolfur Palsson; Shani Shastri; Andrew S Levey; Mark J Sarnak
Journal:  Clin J Am Soc Nephrol       Date:  2015-08-18       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.